🔬Deep Research
GMED — Globus Medical · catalysts, narrative & risks
Globus Medical (NYSE: GMED) — As of 2026-09-25
Background context (unverified): NYSE-listed, Healthcare/Medical Devices, market cap ~$9.93B (2026-09-23), headquartered in Audubon, Pennsylvania [background], [28].
Recent Catalysts (last ~1–3 months)
The dominant near-term catalyst was the Q2 2026 earnings release on August 6, 2026 (after market close, followed by a 4:30 p.m. ET teleconference) [2], [5], [6]. Reported results:
AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →